https://pmc.ncbi.nlm.nih.gov/articles/PMC7269506/
Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor...
Ibrexafungerp (formerly SCY-078) is a semisynthetic triterpenoid and potent (1→3)-β-d-glucan synthase inhibitor. We investigated the in vitro activity,...
first in classcombination therapyibrexafungerpformerlyscy